Search research articles
Contact Us
Filters
Showing results (61-70 of 83) with videos related to
Page
of 9
Sort By:
Gastro Hep Advances
|
April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Siri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
The American Journal of Gastroenterology
|
September 15, 2023
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Priscila Santiago, Nayantara Coelho-Prabhu, Ryan Lennon, et al.
Journal of Crohn'S & Colitis
|
December 9, 2017
Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease
Amy L Lightner, Nicholas P McKenna, Chung Sang Tse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2024
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium
Parambir S Dulai, Lauren Balmert Bonner, Charlotte Sadler, et al.
International Journal of Dermatology
|
September 22, 2024
Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa
Mika Yamanaka-Takaichi, Soheila Nadalian, Edward V Loftus, et al.
The American Journal of Gastroenterology
|
April 13, 2022
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel
Parambir S Dulai, Victoria Rai, Laura E Raffals, et al.
The American Journal of Gastroenterology
|
February 18, 2018
Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial
Parambir S Dulai, Jay C Buckey, Laura E Raffals, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 83) with videos related to
Sort By:
Page
of 9
Gastro Hep Advances
|
April 20, 2026
Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis
Siri A Urquhart, Prajith Raj Ramesh, Sunanda V Kane, et al.
Inflammatory Bowel Diseases
|
April 9, 2016
Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel
Shane M Devlin, Gil Y Melmed, Peter M Irving, et al.
The American Journal of Gastroenterology
|
September 15, 2023
Baseline Clinical Factors Are Associated With Risk of Complications in Crohn's Disease: Appraisal of the American Gastroenterological Association Clinical Care Pathway
Priscila Santiago, Nayantara Coelho-Prabhu, Ryan Lennon, et al.
Journal of Crohn'S & Colitis
|
December 9, 2017
Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn's Disease
Amy L Lightner, Nicholas P McKenna, Chung Sang Tse, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
April 1, 2019
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases
Konstantinos Papamichael, Adam S Cheifetz, Gil Y Melmed, et al.
Inflammatory Bowel Diseases
|
August 22, 2020
Development of Entrustable Professional Activities for Advanced Inflammatory Bowel Disease Fellowship Training in the United States
Benjamin L Cohen, Zane R Gallinger, Christina Ha, et al.
Alimentary Pharmacology & Therapeutics
|
October 15, 2024
Clinical Trial Design Considerations for Hospitalised Patients With Ulcerative Colitis Flares and Application to Study Hyperbaric Oxygen Therapy in the NIDDK HBOT-UC Consortium
Parambir S Dulai, Lauren Balmert Bonner, Charlotte Sadler, et al.
International Journal of Dermatology
|
September 22, 2024
Differentiating clinical characteristics of perianal inflammatory bowel disease from perianal hidradenitis suppurativa
Mika Yamanaka-Takaichi, Soheila Nadalian, Edward V Loftus, et al.
The American Journal of Gastroenterology
|
April 13, 2022
Recommendations on the Appropriate Management of Steroids and Discharge Planning During and After Hospital Admission for Moderate-Severe Ulcerative Colitis: Results of a RAND Appropriateness Panel
Parambir S Dulai, Victoria Rai, Laura E Raffals, et al.
The American Journal of Gastroenterology
|
February 18, 2018
Hyperbaric oxygen therapy is well tolerated and effective for ulcerative colitis patients hospitalized for moderate-severe flares: a phase 2A pilot multi-center, randomized, double-blind, sham-controlled trial
Parambir S Dulai, Jay C Buckey, Laura E Raffals, et al.
Page
of 9